Research & Development



  陸昔年被這突如其來從天而降的餡餅砸暈了。   負責登記的是一個長得很好看的學姐,看到陸昔年的時候楞了一下。热热色琪琪热影音先锋   “年年,我和你爸去隔壁張叔叔家打麻將,冰箱里有水果餓了自己吃點啊。”全国最大色情成人网站   “主播飄了,鑒定完畢。”   “等一下。”陸昔年從最里面拿了一瓶把車里的醬油換掉。av天堂2018在线观看   窗外烏泱泱的,書店里卻異常明亮。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo